mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |